Robert Martin Motz - Net Worth and Insider Trading
Robert Martin Motz Net Worth
The estimated net worth of Robert Martin Motz is at least $758 dollars as of 2024-11-07. Robert Martin Motz is the Senior Officer of Acerus Pharmaceuticals Corp and owns about 2,106 shares of Acerus Pharmaceuticals Corp (TSX:ASP) stock worth over $758. Details can be seen in Robert Martin Motz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Martin Motz has not made any transactions after 2022-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Martin Motz
Robert Martin Motz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Martin Motz owns 1 companies in total, including Acerus Pharmaceuticals Corp (TSX:ASP) .
Click here to see the complete history of Robert Martin Motz’s form 4 insider trades.
Insider Ownership Summary of Robert Martin Motz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ASP | Acerus Pharmaceuticals Corp | 2022-05-11 | Senior Officer |
Robert Martin Motz Latest Holdings Summary
Robert Martin Motz currently owns a total of 1 stock. Robert Martin Motz owns 2,106 shares of Acerus Pharmaceuticals Corp (TSX:ASP) as of May 11, 2022, with a value of $758.
Latest Holdings of Robert Martin Motz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:ASP | Acerus Pharmaceuticals Corp | 2022-05-11 | 2,106 | 0.36 | 758 |
Holding Weightings of Robert Martin Motz
Robert Martin Motz Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Martin Motz has made a total of 4 transactions in Acerus Pharmaceuticals Corp (TSX:ASP) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Acerus Pharmaceuticals Corp is the acquisition of 100 shares on May 11, 2022, which cost Robert Martin Motz around $440.
Insider Trading History of Robert Martin Motz
- 1
Robert Martin Motz Trading Performance
GuruFocus tracks the stock performance after each of Robert Martin Motz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Martin Motz is -44.57%. GuruFocus also compares Robert Martin Motz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Martin Motz within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Martin Motz's insider trading performs compared to the benchmark.
Performance of Robert Martin Motz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -29.35 |  | | | | |
| Relative Return to S&P 500(%) | -28.48 | | | | | |
Robert Martin Motz Ownership Network
Ownership Network List of Robert Martin Motz
Ownership Network Relation of Robert Martin Motz
Robert Martin Motz Owned Company Details
What does Acerus Pharmaceuticals Corp do?
Who are the key executives at Acerus Pharmaceuticals Corp?
Robert Martin Motz is the Senior Officer of Acerus Pharmaceuticals Corp. Other key executives at Acerus Pharmaceuticals Corp include and Director & Senior Officer Edward Joseph Gudaitis .
Acerus Pharmaceuticals Corp (TSX:ASP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acerus Pharmaceuticals Corp (TSX:ASP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acerus Pharmaceuticals Corp (TSX:ASP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acerus Pharmaceuticals Corp (TSX:ASP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acerus Pharmaceuticals Corp Insider Transactions
Robert Martin Motz Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Martin Motz. Currently GuruFocus does not have mailing address information for Robert Martin Motz.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
